{"id":"https://openalex.org/W2921201565","doi":"https://doi.org/10.1182/blood-2018-99-119346","title":"Interleukin-6 Adversely Impacts Genomic Stability Via Targeting Multiple Pathways in Multiple Myeloma","display_name":"Interleukin-6 Adversely Impacts Genomic Stability Via Targeting Multiple Pathways in Multiple Myeloma","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2921201565","doi":"https://doi.org/10.1182/blood-2018-99-119346","mag":"2921201565"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-119346","doi":"https://doi.org/10.1182/blood-2018-99-119346","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119346","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038906755","display_name":"Chaitanya Yenumula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chaitanya Yenumula","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112389374","display_name":"Srikanth Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Srikanth Talluri","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110455648","display_name":"Tommaso Perini","orcid":"https://orcid.org/0000-0002-8439-403X","observed_orcids":["https://orcid.org/0000-0002-8439-403X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tommaso Perini","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103420970","display_name":"Subodh Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Subodh Kumar","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027257617","display_name":"Jialan Shi","orcid":"https://orcid.org/0000-0001-5642-5436","observed_orcids":["https://orcid.org/0000-0001-5642-5436"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jialan Shi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056254084","display_name":"RAO H. PRABHALA","orcid":"https://orcid.org/0000-0002-6375-0437","observed_orcids":["https://orcid.org/0000-0002-6375-0437"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rao Prabhala","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Munshi","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5038906755","https://openalex.org/A5063099799","https://openalex.org/A5103420970","https://openalex.org/A5110455648","https://openalex.org/A5112389374"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801671727","https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"4467","last_page":"4467"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9419999718666077},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.9950000047683716},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9769999980926514},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8100000023841858},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.7919999957084656},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.7739999890327454},{"id":"https://openalex.org/keywords/rpa32","display_name":"RPA32","score":0.8050000071525574},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.8679999709129333},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.9779999852180481},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.6700000166893005},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.6179999709129333},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.7649999856948853},{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.8169999718666077},{"id":"https://openalex.org/keywords/dna-end-resection","display_name":"DNA end resection","score":0.6290000081062317},{"id":"https://openalex.org/keywords/apobec","display_name":"APOBEC","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.9300193786621094},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5897117257118225},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5545491576194763},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.47038236260414124},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4646420478820801},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.41163116693496704},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.28740715980529785},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.28539103269577026}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-119346","doi":"https://doi.org/10.1182/blood-2018-99-119346","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119346","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3178107121","https://openalex.org/W3097451275","https://openalex.org/W2979979666","https://openalex.org/W2048888997","https://openalex.org/W3176076427","https://openalex.org/W2560598769","https://openalex.org/W2594634994","https://openalex.org/W2590532285","https://openalex.org/W2979579773","https://openalex.org/W2525392096"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"our":[2,355],"previous":[3],"investigation,":[4],"using":[5,508],"whole":[6],"exome":[7],"sequencing,":[8],"we":[9,58,98,204,220,373,521],"have":[10,59,81,99,205,468,621],"shown":[11,60,470],"that":[12,61,84,107,208,339,471,534,595],"multiple":[13],"myeloma":[14],"(MM)":[15],"patients":[16],"display":[17],"a":[18,162,212,245,262,327,443],"complex":[19],"dynamic":[20],"of":[21,27,44,133,183,215,224,228,239,251,266,275,301,319,360,366,378,385,394,408,418,422,427,432,456,473,497,502,530,536,546,555,574,583,601,615,635],"clonal":[22],"evolution":[23,626],"and":[24,35,70,120,122,146,198,256,277,307,323,368,460,528,532,576,603,608,627],"the":[25,42,46,102,131,173,180,222,249,310,317,376,383,392,416,454,560],"number":[26,393,421,455,504,545],"mutations":[28],"in":[29,51,78,94,105,155,157,190,218,226,248,290,332,335,345,351,364,371,391,410,453,458,544,550,569,580,587,606],"patient":[30],"samples":[31],"correlate":[32],"with":[33,117,140,179,201,269,309,405,436,525],"overall":[34],"relapse":[36],"free":[37],"survival.":[38],"These":[39,186],"results":[40],"highlight":[41],"importance":[43],"understanding":[45],"mechanisms":[47,54,347,614],"driving":[48],"genomic":[49,56,76,92,110,216,349,428,465,485,519,616,625],"instability":[50,77,93,217,350,617],"MM.":[52,79,95,352],"Investigating":[53],"underlying":[55,348],"instability,":[57,486,520],"dysregulated":[62],"homologous":[63],"recombination":[64],"(HR),":[65],"nuclease":[66,363,387],"(especially":[67],"apurinic/apyrimidinic":[68,361],"related)":[69],"APOBEC":[71],"deaminase":[72],"activities":[73],"contribute":[74],"to":[75,91,175,272,304,326,400,442,449,599,623],"We":[80,112,467],"also":[82,89,297,374,558],"demonstrated":[83,152,207],"bone":[85],"marrow":[86],"microenvironment":[87],"(BMM)":[88],"contributes":[90,598],"So":[96],"here":[97],"further":[100,328,414],"investigated":[101,221,415],"soluble":[103,341],"factors":[104,342],"BMM":[106],"may":[108,343],"impact":[109,125,234,377,417,498],"integrity.":[111],"treated":[113,200,522],"RPMI8226":[114],"MM":[115,158,192,267,291,302,433,523,551],"cells":[116,268,303,524],"IL-6,":[118,526],"IL-17":[119,145,322],"TGFb":[121,306],"evaluated":[123,375],"their":[124],"on":[126,235,354,380,420,499],"DNA":[127,136,149,240,562,585],"breaks":[128,563,586],"by":[129,153,231,261,281,314,475,489,538],"monitoring":[130],"levels":[132],"gH2AX":[134,184,567],"(a":[135,237],"break":[137],"marker).":[138],"Treatment":[139,265],"all":[141],"3":[142],"cytokines":[143,320],"(IL-6,":[144,321],"TGFb)":[147,324],"caused":[148,313],"breaks,":[150],"as":[151,159,161,284,286,425,487,492,494],"increase":[154,331,390,445,543],"gH2AX,":[156],"well":[160,285,493],"solid":[163],"tumor":[164],"(esophageal":[165],"cancer)":[166],"cell":[167,193,434],"lines.":[168],"Importantly,":[169],"among":[170],"these":[171,336,340,592],"cytokines,":[172],"exposure":[174,300],"IL-6":[176,225,270,379,409,419,437,596],"was":[177,296,403],"associated":[178],"highest":[181,311],"induction":[182,312],"expression.":[185],"observations":[187],"were":[188],"confirmed":[189],"additional":[191],"lines":[194,435],"(MM1S,":[195],"H929,":[196],"OPM2":[197],"U266)":[199],"IL-6.":[202,315],"Since":[203],"previously":[206,469],"elevated":[209],"HR":[210,229,257,288,294,333,367,474,514,537,602,611],"is":[211,244],"key":[213],"mechanism":[214],"MM,":[219,372,607],"role":[223,359],"dysregulation":[227,600],"pathway":[230],"evaluating":[232],"its":[233],"p-RPA32":[236,276],"marker":[238,426],"end":[241],"resection":[242],"which":[243],"decisive":[246],"step":[247],"initiation":[250],"HR),":[252],"recombinase":[253],"(RAD51)":[254],"expression":[255,274],"activity":[258,289,295,334],"(as":[259,279,564],"assessed":[260,488,565],"functional":[263],"assay).":[264],"led":[271,325,441],"increased":[273,287,464],"RAD51":[278,476],"detected":[280],"Western":[282],"blotting)":[283],"cells.":[292,412,552,571,589],"Increased":[293],"observed":[298,404,533],"following":[299],"IL-17,":[305],"IFNb,":[308],"However,":[316],"combination":[318,529,573],"(>":[329],"2-fold)":[330],"cells,":[337,462],"indicating":[338,463],"interact":[344],"inducing":[346],"Based":[353],"data":[356,593],"showing":[357],"important":[358],"(AP)":[362],"regulation":[365],"genome":[369,604],"stability":[370,605],"abasic":[381,395],"sites,":[382],"substrate":[384],"AP":[386],"activity.":[388],"An":[389],"sites":[396],"(ranging":[397,446],"from":[398,447,566],"1.7-":[399],"2.3-fold":[401],"increase)":[402,452],"increasing":[406],"concentration":[407],"MM1S":[411,459,570,588],"To":[413,511],"micronuclei,":[423],"used":[424],"instability.":[429,466],"The":[430],"treatment":[431],"for":[438],"48":[439],"hrs":[440],"dose-dependent":[444],"2-":[448],">":[450],"2.5-fold":[451],"micronuclei":[457,490,547],"RPMI":[461],"inhibition":[472,515,535,582],"knockdown":[477],"or":[478],"ABL":[479],"kinase":[480],"inhibitor,":[481],"nilotinib,":[482],"significantly":[483,597],"reduces":[484],"assay":[491],"direct":[495],"evaluation":[496],"genomewide":[500],"acquisition":[501],"copy":[503],"changes":[505],"over":[506],"time":[507],"SNP":[509],"arrays.":[510],"investigate":[512],"if":[513],"can":[516,540],"reverse":[517,541],"IL-6-induced":[518,542],"nilotinib":[527,539,575],"both":[531],"(by":[548],"48\u00b117%)":[549],"Similarly,":[553],"addition":[554],"anti-IL-6":[556,619],"antibody":[557,578],"reversed":[559],"IL6-induced":[561,584],"expression)":[568],"Moreover,":[572],"anti-IL6":[577],"resulted":[579],"maximum":[581],"Taken":[590],"together,":[591],"suggest":[594],"agents":[609],"targeting":[610],"and/or":[612],"other":[613],"including":[618],"antibody,":[620],"potential":[622],"reduce/delay":[624],"disease":[628],"progression.":[629],"Disclosures":[630],"Munshi:":[631],"OncoPep:":[632],"Other:":[633],"Board":[634],"director.":[636]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-03-22T00:00:00"}